Clinical trial
Studies of the Prevention of Atrial Fibrillation by ALA
NCT00410839 · University of Toronto, Other · Unknown status
Key facts
| NCT number | NCT00410839 |
|---|---|
| Title | Studies of the Prevention of Atrial Fibrillation by ALA |
| Official title | Prevention of Atrial Fibrillation Recurrence By An Alpha-Linolenic Enriched Diet - A Pilot Study |
| Lead sponsor | University of Toronto, Other |
| Collaborators | University Hospital, Bordeaux Institut National de la Santé Et de la Recherche Médicale, France |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Atrial Fibrillation, Diet Therapy |
| Intervention type | Procedure |
| Interventions | ALA rich diet |
| Enrollment | 130 |
| Start date | Jun 1, 1999 |
| Completion | Jun 1, 2003 |
| First posted | Dec 13, 2006 |
| Last update posted | Dec 13, 2006 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: